Pharmacology Mogamulizumab was approved by FDA recently for A Prostate cancer B Breast cancer C Hodgkins lymphoma D Non-Hodgkins lymphoma 💡 Explanation Mogamulizumab was approved by FDA recently for ✓ Correct Answer: D. Non-Hodgkins lymphoma